Patient information on nebulised antibiotics.
The importance of providing patients with high-quality information is highlighted in several government reports. The aim of this project was to develop written information specifically designed for patients with non-cystic fibrosis bronchiectasis who are prescribed nebulised colistimethate sodium. This involved evaluating current literature and best practice, which was achieved through multidisciplinary collaboration. The leaflet produced meets the recommendations of the British Thoracic Society and Department of Health, as well as NHS trusts' legal obligations to promote equality and diversity. It is available as a printed document in a variety of formats and languages, and can be downloaded from the hospital website.
Royal Liverpool and Broadgreen University Hospitals NHS Trust.
Bev
B
McDonough
Carol
C
Kelly
D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D001987:Bronchiectasis / Q000188:drug therapy*; D006801:Humans; D009330:Nebulizers and Vaporizers
D000900:Anti-Bacterial Agents